RightFit
RecruitingPhase not listed

EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine

Enduring Migraine Benefit From Responsive Artery Coil Embolization - Observational (EMBRACE-OBS): A Single-Site Registry of Patient-Reported Outcomes Following Routine Clinical Care for Migraine

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years to 64 Years
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study reviews reports from adults ages 18 to 64 with migraine who have had or plan to have MMA embolization, a procedure that blocks a blood vessel near the brain. It tracks changes in headaches, medicine use, daily life, and reported health problems using information already collected during regular care. The study does not change patients’ care.

EMBRACE-OBS is the first phase of the EMBRACE research program. This single-site observational registry accesses and analyzes patient-reported outcome data already collected through routine clinical care from adults with migraine who have undergone or plan to undergo middle meningeal artery (MMA) embolization. The study describes changes in headache frequency, headache severity, medication use, migraine-related disability, quality of life, and reported adverse events over time without influencing clinical care.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Are 18 to 64 years old.
  • Have been diagnosed with migraine.
  • Have had or plan to have MMA embolization as part of regular care, whether or not you join the study.
  • Can and are willing to give informed consent, meaning you understand the study and agree to join.
  • Can read and understand enough English to give consent and complete reports about your health.

Who can't join

  • Are younger than 18.
  • Are pregnant when you join the study.
  • Cannot give informed consent.
  • Cannot read and understand enough English to give consent and complete reports about your health.
  • Do not have enough medical information or reports about your health for the study’s planned review.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Adults aged 18 to 64 years * Diagnosis of migraine * Have undergone or plan to undergo middle meningeal artery (MMA) embolization as part of routine clinical care, independent of study participation * Able and willing to provide informed consent * Able to read and understand English sufficiently to complete informed consent and patient-reported outcome assessments Exclusion Criteria: * Age under 18 years * Pregnancy at the time of enrollment * Inability to provide informed consent * Inability to read and understand English sufficiently to complete informed consent and patient-reported outcome assessments * Insufficient clinical or patient-reported outcome data for the planned analyses

Study sites (1)

WA